Global Metabolomics Market Trends, Analysis, Growth, and Forecast: 2017 to 2026

MarketResearch.biz delivers in-depth insights on the global metabolomics market in its upcoming report titled, “Global Metabolomics Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global metabolomics market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global metabolomics market report has been segmented on the basis of product and service, application, indication, and region.

Metabolomics is a rapidly emerging field which uses analytical processes such as chromatography, spectroscopy, and multivariable analysis allowing scientists to measure the physiological effects. It is also used to monitor the adverse drug reaction and thus has led to the improvement in the diagnosis and treatment process of human diseases. Metabolomics is used in understanding the biology of an organisms, its interaction with environment as well as its genetic makeup.

Wide applications of metabolomics in various fields which includes agriculture industry, biomarker discovery, and personalized medicines are major factors expected to drive the growth of global metabolomics market over the forecast period. Furthermore, increasing government funding by public and private institutes in the field of research and development is expected to propel the market growth over the forecast period. Rising demand for personalized medicine is another factor expected to contribute to the growth of the market over the forecast period.

However, high cost of tools and instruments and need for skilled personnel is expected to limit the market growth over the forecast period.

North America market dominates the global metabolomics market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to increasing need for accurate diagnosis of diseases, presence of large number of manufacturers, and availability of skilled professionals in the region. Europe accounts for second-largest revenue share contribution to the global metabolomics market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to the improving healthcare infrastructure, increasing number of research institutes and government funding’s in the region.

Global metabolomics market segmentation, by Product and Service:

• Metabolomic Instruments
  • Separation Techniques
    • Gas Chromatography (GC)
    • Capillary Electrophoresis (CE)‏
    • High Performance Liquid Chromatography (HPLC)‏
    • Ultra Performance Liquid Chromatography (UPLC)‏
  • Detection Techniques
    • Nuclear Magnetic Resonance Spectroscopy (NMR)‏
    • Mass Spectrometry (MS)
  • Metabolomics Bioinformatics Tools and Services
    • Bioinformatics Tools & Databases
    • Bioinformatics Services

Global metabolomics market segmentation, by application:

• Drug Discovery
• Biomarker Discovery
• Nutrigenomics
• Clinical toxicology
• Others (Functional Genomics, Personalized Medicine)

 Global metabolomics market segmentation, by indication:

• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Others

Global metabolomics market segmentation, by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Thermo Fisher Scientific
• Agilent Technologies, Inc.
• Waters Corporation
• Danaher Corporation
• Shimadzu Corporation
• Biocrates Life Sciences AG
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Human Metabolome Technologies, Inc.
• Leco Corporation